{"rows":[{"id":2885,"title":"A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.","authors":"Sugrue MF","journal":"British journal of pharmacology","publication_date":"1969-02-01","publication_year":1969,"doi":"10.1111/j.1476-5381.1969.tb07983.x","pubmed_id":"5774043","openalex_id":"https://openalex.org/W2022626595","source_url":"https://pubmed.ncbi.nlm.nih.gov/5774043/","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:15","last_checked":"2026-08-09 08:28:31","bibtex":null,"source_record_id":"PMID:5774043","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/5774043/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:5774043","source_url":"https://pubmed.ncbi.nlm.nih.gov/5774043/","doi":"10.1111/j.1476-5381.1969.tb07983.x","pmid":"5774043","publication_date":"1969-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2875,"title":"Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).","authors":"Meldrum BS, Naquet R","journal":"British journal of pharmacology","publication_date":"1970-09-01","publication_year":1970,"doi":null,"pubmed_id":"4992165","openalex_id":"https://openalex.org/W51306571","source_url":"https://pubmed.ncbi.nlm.nih.gov/4992165/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:15","last_checked":"2026-08-09 08:34:29","bibtex":null,"source_record_id":"PMID:4992165","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:4992165","source_url":"https://pubmed.ncbi.nlm.nih.gov/4992165/","doi":"","pmid":"4992165","publication_date":"1970-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1012,"title":"Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.","authors":"Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Jones JA, McMurray MS","journal":"British journal of pharmacology","publication_date":"2024-10-01","publication_year":2024,"doi":"10.1111/bph.16466","pubmed_id":"38825326","openalex_id":"https://openalex.org/W4399276098","source_url":"https://pubmed.ncbi.nlm.nih.gov/38825326/","substance_tags":"psilocybin,psilocin","topic_tags":"Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Aging,In Vitro Study,Safety","study_type":"In Vitro Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:38825326","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38825326/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38825326","source_url":"https://pubmed.ncbi.nlm.nih.gov/38825326/","doi":"10.1111/bph.16466","pmid":"38825326","publication_date":"2024-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":21,"title":"Chemistry/structural biology of psychedelic drugs and their receptor(s).","authors":"Gumpper RH, Nichols DE","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.17361","pubmed_id":"39354889","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39354889/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:47","bibtex":null,"source_record_id":"PMID:39354889","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39354889/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39354889","source_url":"https://pubmed.ncbi.nlm.nih.gov/39354889/","doi":"10.1111/bph.17361","pmid":"39354889","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":20,"title":"Psilocybin as a novel treatment for chronic pain.","authors":"Askey T, Lasrado R, Maiarú M, Stephens GJ","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.17420","pubmed_id":"39614355","openalex_id":"https://openalex.org/W4404843727","source_url":"https://pubmed.ncbi.nlm.nih.gov/39614355/","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Animal Study,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:39614355","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39614355/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39614355","source_url":"https://pubmed.ncbi.nlm.nih.gov/39614355/","doi":"10.1111/bph.17420","pmid":"39614355","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":19,"title":"The Australia story: Current status and future challenges for the clinical applications of psychedelics.","authors":"Nutt DJ, Hunt P, Schlag AK, Fitzgerald P","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.17398","pubmed_id":"39701143","openalex_id":"https://openalex.org/W4405565174","source_url":"https://pubmed.ncbi.nlm.nih.gov/39701143/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:39701143","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39701143/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39701143","source_url":"https://pubmed.ncbi.nlm.nih.gov/39701143/","doi":"10.1111/bph.17398","pmid":"39701143","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":18,"title":"Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.","authors":"Sharp T, Ippolito A","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.70050","pubmed_id":"40405723","openalex_id":"https://openalex.org/W4410698430","source_url":"https://pubmed.ncbi.nlm.nih.gov/40405723/","substance_tags":"psilocin","topic_tags":"Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:40405723","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40405723/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40405723","source_url":"https://pubmed.ncbi.nlm.nih.gov/40405723/","doi":"10.1111/bph.70050","pmid":"40405723","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":17,"title":"Psychedelics, entactogens and psychoplastogens for depression and related disorders.","authors":"Hoyer D","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.70088","pubmed_id":"40518133","openalex_id":"https://openalex.org/W4411319821","source_url":"https://pubmed.ncbi.nlm.nih.gov/40518133/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:40518133","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40518133/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40518133","source_url":"https://pubmed.ncbi.nlm.nih.gov/40518133/","doi":"10.1111/bph.70088","pmid":"40518133","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":16,"title":"Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.","authors":"Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.70109","pubmed_id":"40545270","openalex_id":"https://openalex.org/W4411528016","source_url":"https://pubmed.ncbi.nlm.nih.gov/40545270/","substance_tags":"psilocin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:40545270","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40545270/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40545270","source_url":"https://pubmed.ncbi.nlm.nih.gov/40545270/","doi":"10.1111/bph.70109","pmid":"40545270","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":15,"title":"Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?","authors":"Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.70138","pubmed_id":"40726049","openalex_id":"https://openalex.org/W4412727285","source_url":"https://pubmed.ncbi.nlm.nih.gov/40726049/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study,Inflammation,Immune Function","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:40726049","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40726049/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40726049","source_url":"https://pubmed.ncbi.nlm.nih.gov/40726049/","doi":"10.1111/bph.70138","pmid":"40726049","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":14,"title":"Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.","authors":"Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D","journal":"British journal of pharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1111/bph.70181","pubmed_id":"40891276","openalex_id":"https://openalex.org/W4413906381","source_url":"https://pubmed.ncbi.nlm.nih.gov/40891276/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:40891276","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40891276/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40891276","source_url":"https://pubmed.ncbi.nlm.nih.gov/40891276/","doi":"10.1111/bph.70181","pmid":"40891276","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}}],"total":11,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"British journal of pharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}